These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 11501322)
1. TNF alpha blockade in rheumatoid arthritis--time for caution or enthusiasm? Hamilton JD; Wilson HE; Madhok R; McInnes IB; Capell HA Scott Med J; 2001 Jun; 46(3):67-70. PubMed ID: 11501322 [No Abstract] [Full Text] [Related]
2. Do we really need five TNF antagonists? Ruderman EM Rheumatology (Oxford); 2010 Jun; 49(6):1028-9. PubMed ID: 20172993 [No Abstract] [Full Text] [Related]
3. [TNF-inhibitors slow down joint destruction in rheumatoid arthritis. No cure, but dramatic relief of symptoms]. Wollheim FA Lakartidningen; 2001 May; 98(21):2560-2. PubMed ID: 11433990 [No Abstract] [Full Text] [Related]
4. If it works why can't we have it? Sequential anti-TNF therapy in the UK. Deighton C Rheumatology (Oxford); 2010 Dec; 49(12):2235-6. PubMed ID: 20685801 [No Abstract] [Full Text] [Related]
6. [TNF-alpha blocker in rheumatoid arthritis. Who should be treated with the new substances?]. MMW Fortschr Med; 2000 Nov; 142(44):6. PubMed ID: 11107796 [No Abstract] [Full Text] [Related]
7. Synovial synoviolin in relation to response to TNF blockade in patients with rheumatoid arthritis and psoriatic arthritis. Klaasen R; Wijbrandts CA; van Kuijk AW; Pots D; Gerlag DM; Tak PP Ann Rheum Dis; 2012 Jul; 71(7):1260-1. PubMed ID: 22345123 [No Abstract] [Full Text] [Related]
8. [TNF-alpha antagonists in therapy of rheumatoid arthritis]. Gross WL; Gause A Z Rheumatol; 2003 Jun; 62(3):217. PubMed ID: 12931691 [No Abstract] [Full Text] [Related]
10. BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy. Deighton C; Hyrich K; Ding T; Ledingham J; Lunt M; Luqmani R; Kiely P; Bukhari M; Abernethy R; Ostor A; Bosworth A; Gadsby K; McKenna F; Finney D; Dixey J; Rheumatology (Oxford); 2010 Jun; 49(6):1197-9. PubMed ID: 20308121 [No Abstract] [Full Text] [Related]
11. Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade: comment on the article by Buch et al. Schiff MH Arthritis Rheum; 2005 Jan; 52(1):364-5; author reply 365. PubMed ID: 15641081 [No Abstract] [Full Text] [Related]
12. The new era in the treatment of rheumatoid arthritis. Putterman C Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):2-4. PubMed ID: 17694188 [No Abstract] [Full Text] [Related]
13. [TNF antagonists in therapy of rheumatoid arthritis]. Oberpichler-Schwenk H Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266 [No Abstract] [Full Text] [Related]
17. Chronic viral hepatitis and TNF-alpha blockade. Raftery G; Griffiths B; Kay L; Kane D Rheumatology (Oxford); 2007 Aug; 46(8):1381; author reply 1381-2. PubMed ID: 17567635 [No Abstract] [Full Text] [Related]
18. The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis. Kavanaugh A; Cohen S; Cush JJ J Rheumatol; 2004 Oct; 31(10):1881-4. PubMed ID: 15468347 [No Abstract] [Full Text] [Related]
19. TNF-alpha antagonists and other recombinant proteins for the treatment of rheumatoid arthritis. Brasington R J Hand Surg Am; 2009 Feb; 34(2):349-50. PubMed ID: 19135810 [No Abstract] [Full Text] [Related]
20. [TNF-alpha antagonist in rheumatoid arthritis. Joint destruction can be controlled]. MMW Fortschr Med; 2003 Oct; 145(41):46. PubMed ID: 14655484 [No Abstract] [Full Text] [Related] [Next] [New Search]